Results 171 to 180 of about 48,580 (273)

Cannabis Use Moderates Methamphetamine- and HIV-Related Inflammation: Evidence from Human Plasma Markers. [PDF]

Viruses
Rogers JM, Chentsova VO, Wang CX, Marcondes MCG, Cherner M, Ellis RJ, Letendre SL, Heaton RK, Grant I, Iudicello JE.   +9 more
europepmc   +1 more source

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia [PDF]

, 2019
et al,, Uy, Geoffrey, Yeshurun, Moshe
core   +1 more source

Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. [PDF]

Blood Adv
Bhatt NS, Borogovac A, Efebera YA, DeSalvo A, Devine SM, Foley A, Greco-Stewart V, Hamilton BK, Heuer M, Molfenter T, Plastaras JP, Ragon BK, Wall SA, Broglie L, Juckett MB, Khera N, Horowitz MM, DeZern AE.   +17 more
europepmc   +1 more source

The role of brain creatine in behavioral health conditions. [PDF]

Front Psychiatry
Han ES, Yancey JR, Yurgelun-Todd DA, Kondo DG, Boxer DJ, Renshaw PF.   +5 more
europepmc   +1 more source

Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. [PDF]

, 1993
Celli, S, Demetris, AJ, Frye, C, Fung, JJ, Murase, N, Starzl, TE, Valdivia, LA   +6 more
core  

Standardized Thalassotherapy Versus Conventional Rehabilitation in Post-Traumatic Patients: Clinical, Biochemical, and Quality-of-Life Outcomes. [PDF]

Healthcare (Basel)
Mihai M, Adriana NS, Mitoiu BI, Sachelarie L, Nartea R.   +4 more
europepmc   +1 more source

The Nephrotoxicity of Vancomycin. [PDF]

, 2017
Farber, John L., Filippone, Edward J., Kraft, Walter K.   +2 more
core   +2 more sources

Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. [PDF]

Transplant Cell Ther
Jimenez Jimenez AM, Spellman SR, Politikos I, McCurdy SR, Devine SM, Malki MMA, Bolon YT, Lee SJ, Dehn J, Pidala J, Maiers M, Askar M, Malmberg C, Auletta JJ, Stefanski H, Broglie L, Qayed M, Horwitz M, Wilder JS, Gooptu M, Mehta RS, Fernandez-Viña M, Shaw BE, Shaffer BC.   +23 more
europepmc   +1 more source

Non-muscle myosin II is a promising therapeutic target. [PDF]

Trends Pharmacol Sci
Miller CA, Quinones-Hinojosa A, Rosenfeld SS.   +2 more
europepmc   +1 more source

Which liver-disease patients need a transplant? [PDF]

, 1988
Gordon, RD, Iwatsuki, S, Kahn, D, Klintmalm, G, Koneru, B, Makowka, L, Marsh, JW, Sher, L, Starzl, TE, Staschak, S, Stieber, A, Todo, S, Tzakis, AG, Van Thiel, D   +13 more
core